CHRISTINE SINCLAIR: Open Payments
NPI 1457642688 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 24 payments from 10 companies in 2025. Trend: 2023 $1,347 · 2024 $897 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $108 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $57 |
| ABBVIE INC. | 3 | $52 |
| Alkermes, Inc. | 2 | $51 |
| Lundbeck LLC | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: REXULTI, FANAPT, TRINTELLIX, AUSTEDO XR, INVEGA SUSTENNA, VRAYLAR, ARISTADA, HETLIOZ.
Industry payments across AR — which companies pay providers there.
